Filing Details
- Accession Number:
- 0001225208-16-036059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-05 12:56:17
- Reporting Period:
- 2016-07-01
- Filing Date:
- 2016-07-05
- Accepted Time:
- 2016-07-05 12:56:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181175 | C Kenneth Frazier | Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-01 | 32,379 | $51.02 | 554,856 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-01 | 32,379 | $58.00 | 522,477 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-07-05 | 27,621 | $51.02 | 550,098 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-05 | 27,621 | $58.00 | 522,477 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-07-01 | 32,379 | $0.00 | 32,379 | $51.02 |
| Common Stock | Stock Option (right to buy) | Disposition | 2016-07-05 | 27,621 | $0.00 | 27,621 | $51.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,621 | 2008-08-01 | 2017-07-31 | No | 4 | M | Direct |
| 0 | 2008-08-01 | 2017-07-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock - 401(K) Plan | 3,699 | Indirect | By 401(k) |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Holdings include shares acquired in dividend reinvestment transactions.
- Includes shares acquired and dividends earned through April 7, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
- The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010.
Billionaire Hedge Funds
